Janney Downgrades Champions Oncology (CSBR) to Neutral
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.95 -0.8%
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 3
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 3
Join SI Premium – FREE
Janney analyst Paul Knight downgraded Champions Oncology (NASDAQ: CSBR) from Buy to Neutral.
For an analyst ratings summary and ratings history on Champions Oncology click here. For more ratings news on Champions Oncology click here.
Shares of Champions Oncology closed at $7.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Downgrades Carl Zeiss Meditec AG (AFXG:GR) (CZMWY) to Reduce
- Freedom Broker Downgrades Geodrill Limited (GEO:CN) (GDLLF) to Hold
- UBS Downgrades Coca-Cola Europacific Partners (CCEP) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
